Omnicell公司2024年第三季度业绩超出华尔街预期,业绩和财务指引利好利好消息推动其股价在10月30日当天大涨37.76%。
数据显示,Omnicell第三季度每股收益为0.56美元,高于一致预期的0.4美元。营收达到2.82亿美元,也超出了2.8亿美元的市场预期。强劲的业绩表现令该公司上调了2024财年的财务指引,预计全年每股收益在1.65至1.72美元区间,总营收在 1100 至 1110 亿美元区间,均高于之前的目标区间。
良好的业绩和前景预期显著提振了机构投资者对Omnicell的信心,推动其盘中股价出现大涨。目前9名分析师有4名给予该股买入或强烈买入评级。在所属的医疗信息服务行业整体向好的背景下,投资者普遍看好Omnicell未来的增长潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.